Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LaserSight Technologies, Inc. was a pioneering medical technology company that specialized in the development and commercialization of excimer laser systems for refractive surgery. The company was best known for its LaserScan LSX and AstraScan systems, which were among the first to utilize scanning-spot technology to treat vision impairments such as myopia, hyperopia, and astigmatism. Founded in 1991, LaserSight played a critical role in the early evolution of LASIK procedures and held a significant portfolio of intellectual property in the field. Despite its technical innovations, the company faced intense competition and protracted patent litigation with industry giants like VISX. Ultimately, LaserSight sold its core laser assets to VISX in the early 2000s and ceased independent manufacturing operations. Today, the LaserSight name is primarily associated with various ophthalmic clinics and historical contributions to laser vision correction technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LaserSight.